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Each year, Jefferson surgeons perform 
over 200 pancreatic resections, 
including more than 130 “Whipple 
procedures” — making the hospital #1 
in surgical volume for pancreatic 
cancer and related diseases in the 
tristate region of Pennsylvania,  
New Jersey and Delaware.  
“While we are very proud of what  
we have achieved, there are always 
opportunities for improvement,” says 
Charles J. Yeo, MD, FACS, Samuel D. 
Gross Professor and Chair of Surgery, 
who has personally performed more 
than 1,400 Whipple procedures and 
treated thousands of patients with 
pancreatic cancer and related diseases. 
Beyond the impressive numbers, the 
Jefferson Pancreas, Biliary and Related 
Cancer Center offers much more: 
multidisciplinary diagnosis and 
treatment, groundbreaking clinical 
research, and active involvement in 
community events — such as Amy’s 
Ride/Run/Walk in Quakertown (May 
20) and Pancreatic Cancer Action 
Network’s PurpleStride (November 4). 
New Multidisciplinary Pancreatic 
Cancer Clinic
When pancreatic cancer is suspected, 
many patients and their families feel 
overwhelmed. In addition to the 
emotional impact, patients may have to 
schedule several appointments to see 
primary doctors and gastroenterologists, 
as well as surgeons, medical oncologists 
and radiation oncologists. At our 
Multidisciplinary Pancreatic Cancer 
Clinic, all relevant clinicians gather 
each Monday afternoon to review 
cases and see patients — providing 
the convenience of multiple 
appointments during a single visit.
Development of a National Cancer 
Institute Funded Research Program
Since his recruitment in 2006, 
Jonathan Brody, PhD, Vice Chair  
for Research in the Department of 
Surgery, has been building a world-
class pancreatic cancer research 
program. Dr. Brody specializes in 
studying the molecular basis of 
cancer development and progression, 
targeted therapy and personalized 
medicine. As a translational researcher, 
he steers the research trajectory of 
the Brody Laboratory while serving 
as an advisor/collaborator to all 
levels of trainees as well as our 
practicing surgeons, including Drs. 
Harish Lavu and Jordan Winter. 
Ongoing Clinical Trials
Harish Lavu, MD, FACS, is leading the 
Whipple Accelerated Recovery Pathway 
(WARP) trial aimed at supporting faster 
recovery from pancreatic surgery. In 
2007, the team conducted a similar 
study that established the seven-day 
“Critical Pathway” standard at Jefferson. 
The WARP trial — initiated in late 2015 
and with nearly 70 patients enrolled 
to date — is testing a five-day pathway. 
The protocol incorporates in-hospital 
physical therapy, specific dietary 
recommendations and rigorous 
monitoring following discharge. 
Meanwhile, Jordan M. Winter, MD, 
FACS, is tackling a perennial patient 
query: “Can pancreatic surgery make 
the cancer ‘spread’?” To explore this 
topic, Dr. Winter is leading the Water 
or Saline at High Volumes (WASH) 
trial that is testing the use of 10 liters of 
plain water or salt water for abdominal 
washing immediately following removal 
of the tumor. Current practice uses 
just one or two liters of saline at the 
conclusion of the procedure. The 
study, started in April 2016 with more 
than 100 patients enrolled to date, 
aims to expand to other sites and 
enroll 800 patients.
For more information, go to 
Jefferson.edu/Pancreas.
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Our multidisciplinary pancreatic cancer team includes surgeons, GI specialists, medical oncologists,  
radiation oncologists, advanced practice nurses, research scientists, residents, postdoc fellows, graduate 
students, clinical research coordinators and nutritionists.
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High Volume, Top Quality, and Rigorous Research: 
Jefferson Sets New Standards in Pancreatic Cancer Care
“In Asia, average hospital stay for pancreatic surgery patients is 21 days. 
In Europe, it’s 14 days. In most U.S. hospitals, it’s 12 to 14 days. Here at 
Jefferson, our current seven-day stay requires tremendous coordination 
across the Surgery, ICU and Nursing teams. With the WARP trial, we are 
trying to do something few others have consistently been able to do: 
improve outcomes by safely discharging Whipple procedure patients 
after just 5 days.
“Why are shorter hospital stays better? Research has shown that being in a hospital when you 
aren’t critically ill actually delays healing and exposes patients to hospital-acquired infections. 
We want to prepare our patients to leave the hospital as quickly as possible so they can recover 
safely and more rapidly in the comfort of their own homes.”
Harish Lavu, MD, FACS 
Associate Professor and Chief, Section of Hepatopancreatobiliary Surgery
“Lymphatics, nerves, small blood vessels and tumor margins frequently 
have cancer in them, which can only be appreciated at the microscopic 
level. As we’re dividing these structures, can some of these cells be 
spilled? It isn’t inconceivable. The hypothesis of the WASH study is that 
this high-volume washing may remove those kinds of free-floating 
cancer cells present after the tumor is resected – ultimately helping to  
prolong survival. 
“Very few surgical cancer studies have looked specifically at pancreatic cancer outcomes.  
This trial points to the potential for surgical oncologists to affect cancer outcomes with an 
inexpensive intervention: high-volume abdominal washing. If we can use it to improve survival 
even by a few months, we’re accomplishing the same thing as a billion-dollar drug.” 
Jordan Winter, MD, FACS 
Associate Professor
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On the surface, the proposed merger 
of Thomas Jefferson University and 
Philadelphia University will create one 
comprehensive institution focused  
on professional education in health, 
science, architecture, design, fashion, 
business and engineering. In practice, 
it will integrate different models of 
thought and diverse approaches to 
studying and solving problems — 
enabling us to reimagine a new kind  
of education for the jobs of the future. 
The Combination Agreement was 
signed by both institutions’ Boards  
of Trustees in September 2016. 
Although the merger isn’t expected  
to be completed until later this year, 
the Department of Surgery isn’t 
waiting to initiate collaborations with 
Philadelphia University. With Gerald 
Isenberg, MD, FACS, Professor and 
Director of the Surgical Undergraduate 
Education Program and Colorectal 
Residency Program, serving as the 
Department’s liaison, the team is 
already identifying innovative ways  
to blend resources and expertise. 
Dr. Isenberg recalls the first “road  
trip” that department clinicians and 
researchers took last December to 
the Philadelphia University campus  
in the East Falls section of the city: 
“The facilities were amazing, and 
there was a palpable excitement as 
we toured the campus. Philadelphia 
University works with huge companies 
around the world. They have the 
ability to make virtually anything right 
there on the campus.”
He sees tremendous potential to apply 
those capabilities to further refine  
the field of surgery — from process 
workflows to physical instruments 
used to operate. In fact, one of the 
ideas under consideration is a one-
year Fellowship in which a Department 
of Surgery resident would spend his 
or her research year studying surgical 
process and design problems at 
Philadelphia University. 
“This would be an opportunity to 
infuse fresh perspective to steps that 
we take for granted,” Dr. Isenberg 
explains. “We want to be challenged — 
to strip away ‘that’s how we’ve always 
done it’ thinking.” 
Building on work already underway  
at Jefferson, Scott Cowan, MD, FACS, 
Associate Professor and Vice Chair for 
Quality, is working with Philadelphia 
University on rethinking patient rooms. 
The team is tapping into Philadelphia 
University’s expertise in architecture, 
design and building materials to 
analyze patient room design and 
workflow. Combined insights and 
recommendations could help on a 
number of fronts — from improving 
prevention of healthcare-acquired 
infections to reducing patient fall risk. 
“We have an extraordinary opportunity 
to work together to improve the 
environment of care for our patients,” 
he says. “Philadelphia University’s 
expertise clearly complements what 
we’re doing here in the hospital in terms 
of achieving the highest quality of care.”
Dr. Isenberg notes that the merger will 
also benefit Philadelphia University 
students, with unprecedented access 
to the surgical world helping them 
learn how surgeons approach and 
solve problems.
“An integrated Philadelphia University 
and Thomas Jefferson University 
allows us to reimagine education in  
a way that launches students into the 
careers of their passion in a bigger, 
bolder way,” says Philadelphia University 
President Stephen Spinelli, Jr, PhD. 
“We will prepare students for careers 
of the 21st century, with an emphasis 
on scientific and applied research, 
design thinking and discovery.”
For more information, go to  
wordpress.philau.edu/powered.
Enterprise IntegrationOverview
Charles J. Yeo, MD, FACS 
Samuel D. Gross Professor and Chair 
Department of Surgery
 
The Spring of 
2017…Change 
and Hope 
There is excitement in the air at Jefferson this spring. We had a superb 
“Match” on March 17, and will be welcoming 6 terrific categorical 
general surgery residents come July. The Philadelphia Phillies just 
completed spring training well above .500, and there are high hopes  
for an improved year. In late April, the American Surgical Association −  
co-founded by our very own Dr. Samuel D. Gross (Chair of Surgery, 
1856-1882) − hosted their 137th Annual Meeting here in Philadelphia. 
As part of the social program, attendees toured Lubert Plaza in the heart  
of our Center City campus, which includes the magnificent Samuel 
Gross Monument by Alexander Calder.
Jefferson Health continues to sustain momentum towards further 
expansion, with the planned addition of Kennedy Health in New Jersey 
and Philadelphia University to our Jefferson family soon. Some work 
is already underway with Philadelphia University (see the Enterprise 
Integration column), taking advantage of their expertise in creative 
design, innovation, and space planning. Add to this the work being done 
at our Center City, Abington and Aria campuses by our 7 surgical 2.0 
Integration teams focusing on patient-centered, highest quality care…
much is happening.
April 1 marked the launch of our Wave 2 EPIC implementation 
(inpatient EPIC) at our Jefferson Hospitals in Center City and on our 
Methodist campus. The power of this electronic health record (EHR) 
is quite amazing. Patients are being encouraged to sign up online for 
the “MyChart” patient portal, we are linked to other organizations via 
the Care Everywhere platform, and we now have one unified EHR for 
our outpatient and inpatient environments. As you might imagine, 
the surgical residents have embraced this new technology with great 
enthusiasm, while at least some of us (attending surgeons) are finding  
we have to work a bit harder to become facile. We look forward to 
further optimization of these systems, so that we can truly see the  
power of this far reaching, multi-layered EHR. 
Please enjoy the various articles which compose this issue and  
keep up with our news on Facebook.com/JeffersonSurgery and  
Twitter@JEFFsurgery in between issues. 
Department of Surgery and Philadelphia University 
Lay Groundwork for Collaboration Prior to Merger
A December meeting, led by Stephen Spinelli, Jr, PhD, President of Philadelphia University, and Charles J. Yeo, MD, 
Chair of Surgery at Jefferson (seated, 3rd and 4th from left), gave faculty and staff from both institutions an 
opportunity to brainstorm about future collaborations.
In the Spotlight
Advanced practice nurses Liezl DiDonato, Chuck 
Rowland, Sung Whang, Sophie Mintz, Lori Pelligrino, 
Dana Ovadia, Theresa Yeo, Ling Fan, Linda Martino, 
and Shawnna Cannaday
In September, 10 advanced practice nurses 
from the Department of Surgery gathered for 
a lunchtime kick-off meeting to form a Nurse 
Practitioners (NPs) & Physician Assistants (PAs) 
Professionalism and Scholarship Working 
Group. This initiative is an important career 
development component and has been 
meeting on a monthly basis to discuss issues 
in clinical practice, explore potential clinical 
research projects, foster CV development,  
and address professional practice concerns. 
Thus far, two projects have been submitted 
for small grant consideration, several 
presentations have been developed and two 
members are collaborating on publishing an 
online continuing education module for NPs.
All Department of Surgery NPs  
and PAs are invited. Please contact:  
theresa.yeo@jefferson.edu.
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 Two studies at the Jefferson  
Vascular Center (JVC) are assessing 
innovative methods to reduce risk of 
complications — and increase positive 
outcomes — for vascular surgery 
patients. Here, Paul DiMuzio, MD, 
FACS, William M. Measey Professor  
of Surgery and Co-Director, Jefferson 
Vascular Center, reviews what both 
studies mean for patient care.
‘Game-changer’ for groin wounds
As Dr. DiMuzio explains, groin incisions 
in vascular surgery are a source of 
significant morbidity and healthcare 
costs. When groin wounds become 
infected, patients may have to be 
readmitted and undergo additional 
surgery. Some patients are at greater 
risk because of diabetes and obesity, 
others because of the surgical 
technique required for their treatment. 
In exploring ways to decrease groin 
wound infections in high-risk patients, 
the JVC identified a possible solution 
in PrevenaTM — a sponge covered  
in adhesive that attaches to a small 
suction device. The suction device 
removes fluids from the region, 
helping reduce the risk of infection. 
Already FDA-approved, Prevena is 
used by cardiac surgeons for sternal 
incisions and by orthopedic surgeons 
in total joint replacements. 
“No one had conducted a prospective 
randomized trial to determine if 
Prevena is a viable option for high-
risk groin wounds,” he says. “We  
were the first.”
The results of Jefferson’s two-year 
study — which will be presented  
later this Spring at the 2017 Annual 
Meeting of the Society for Vascular 
Surgery in San Diego — showed a 
significant reduction in infections  
and re-admissions. Hospital costs 
declined by an average of $6,000  
per patient. 
We are now using [the 
Prevena] device for every 
patient with high-risk 
groin incisions, and  
we expect it to become  
a standard of care 
everywhere once the 
findings are published.
“We are now using this device for 
every patient with high-risk groin 
incisions, and we expect it to become 
a standard of care everywhere once 
the findings are published,” he adds. 
“It’s a game changer.”
In February, Megan Lundgren, MD,  
a third-year General Surgery resident 
and Sidney Kimmel Medical College 
alumna, presented the study at the 
Philadelphia Academy of Surgery’s 
Annual Surgical Research Competition. 
Dr. Lundgren, who helped enroll and 
care for trial participants, won the 
inaugural Chris Tzarnas Surgical 
Research Award for the work.
Follow-up trial of new treatment  
for carotid artery disease
Following the promising multi-center 
ROADSTER trial, the ROADSTER 2 trial 
is observing and evaluating real-world 
results of a newly approved procedure 
for treating carotid artery disease.
The most widely used treatment  
for carotid artery disease has been 
the carotid endarterectomy (CEA) 
procedure, in which plaque is surgically 
removed from the blocked artery.  
For patients who may be at high 
medical or anatomic risk for carotid 
endarterectomy, carotid stenting  
may be a better option. Though both 
procedures are generally safe, heart 
attack risk is higher with CEA, while 
stroke risk is higher with stenting. 
Trans-carotid Artery Revascularization 
(TCAR) is designed to lower both 
risks, and the initial ROADSTER trial 
demonstrated its success.
“The TCAR procedure is a hybrid  
of the other two treatments,” Dr. 
DiMuzio says. “It places a carotid 
stent through a minimally invasive 
incision in the carotid artery at the 
level of the neck. Blood flow in  
the artery is temporarily reversed  
to protect the brain from plaque 
fragments that may come loose 
during the procedure. A stent is then 
inserted into the blood vessel to 
support the artery walls and prevent 
blockage or collapse.” Dr. DiMuzio 
adds that stent deployment via access 
directly through the common carotid 
artery avoids the need to traverse the 
aortic arch with catheters, which can 
lead to embolic stroke. 
Though approved by the FDA,  
the TCAR procedure will not be 
marketed until the ROADSTER 2 trial 
is completed. To date, Jefferson is 
the first and only study location in  
the Philadelphia area. Dr. DiMuzio  
and his team have already performed 
the TCAR procedure and are actively 
enrolling more patients.
“Nationally, the study is more than 
halfway to completion — and the 
TCAR procedure is on its way to 
becoming an exciting new standard 
of care for carotid artery disease,”  
he says.
For more information, contact  
the Jefferson Vascular Center  
at 215-955-8304 or visit  
Jefferson.edu/JVC.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
Changing Lives Through Research
Since joining the Department of Surgery 
in 2001 as an administrative assistant in 
the Division of Transplant Surgery, Andrea 
DelMastro has moved to our 1300 Wolf Street 
Office on the Methodist Campus. Born and 
raised in South Philly, she has returned and 
served as the Department’s practice manager 
there for the past five years. 
At Methodist, Andrea oversees day-to-day 
operations of 14 providers and a team of 
registrars, medical assistants and nurse 
practitioners. The practice includes several 
specialties within the Department of Surgery: 
Bariatric, Breast, Colorectal, General, Thoracic 
and Vascular Surgery & Vascular Medicine. 
The services provided there include more than 
just surgical consultations, as several other 
outpatient services are offered, including 
vascular ultrasound, minimally invasive vein 
closure, and wound care.
During the last few years she has been 
active at both campuses taking on a number 
of departmental projects: she is currently 
the Department’s lead for the JeffConnect 
telehealth program and serves as a ‘super 
user’ for the EPIC Electronic Health Record 
implementation. 
Another of DelMastro’s long-term projects 
is contributing to the Methodist Hospital 
Division’s Surgery White Paper. The purpose 
of the ongoing initiative: to identify ways to 
improve both patient experience and overall 
surgical patient throughput at Methodist. 
To date, such improvements have included 
adding a room for private family surgical 
consultations and staffing a patient registrar.
She appreciates the diverse challenges of  
her work: “Every day is different,” she says.  
“I juggle clinic hours, department projects, as 
well as the unique needs of staff and patients 
that come up daily.” DelMastro strives to 
make sure her employees are engaged, as  
she believes that “makes all the difference  
in patient care.”
Above all, Andrea values being part of the 
Methodist community: “I love that I get to 
work in an office where I know the majority 
of my patients from the neighborhood. It’s 
world-class care – with a real hometown feel.” 
The Jefferson Vascular Center surgeons, Drs. Paul DiMuzio, Dawn Salvatore and Babak Abai, rely on the support of 
advanced practice nurses Meghan McCullough, MSN, RN, FNP, AGACNP, and Cara Staley, MSN, RN-BC, AGACNP-BC 
(on either side of Dr. Salvatore) to manage the Prevena and ROADSTER 2 clinical trials.
On the Job
Clinical Studies Target Fewer Complications, 
Better Outcomes for Vascular Surgery
Andrea DelMastro
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Those Who Give
News in Brief 
In 2004, Pennye Goodman received a living donor 
kidney transplant thanks to her donor and brother, 
Gregory Tettemer, and their care team at Jefferson. 
On December 14, Pennye and her husband, Phil, cut 
the ribbon to their Exam Room named for Gregory in 
the Nicoletti Kidney Transplant Center located at the 
corner of 9th and Chestnut Streets in Center City.
Patient-Benefactors Support New Kidney Transplant Center 
SurgicalSolutions
December 14, 2017 was a landmark day at 
Jefferson: the ribbon cutting ceremony of 
the Nicoletti Kidney Transplant Center at 
Jefferson. This milestone venture – bringing 
together research, education and clinical care 
in one space – came to fruition thanks to  
a $2.5 million lead gift from the Robert V. 
Nicoletti Family Trust. The Center emphasizes 
living donor transplantation, something that  
is very personal to the Nicoletti family.
In early 2006, Jefferson doctors determined 
that the patriarch of the family, businessman 
and philanthropist Robert (Bob) V. Nicoletti, 
needed a kidney transplant. Seven members  
of his family immediately volunteered to donate 
a kidney. Ultimately, only one was deemed 
compatible: Bob’s youngest daughter, Lori 
Nicoletti Peruto, Esq. This life-saving kidney 
gave Bob – who passed away in February 2016 
at 85 years-old – another 10 loving years with 
his children and grandchildren.
Inspired by the care they received at Jefferson, 
the Nicolettis became steadfast and generous 
supporters of the Jefferson Transplant Institute. 
In late 2015, Bob and his three children, Mark 
R. Nicoletti, Sr., Lori Nicoletti Peruto, Esq., and 
Donna Nicoletti Ferrier, along with their spouses, 
provided the leadership gift to name the new 
Center. This kicked off a campaign supported 
by other grateful patients, Jefferson leadership 
and community partners to build a more robust 
living donor kidney transplant program.
Living donor transplants generally 
work better and last almost twice as 
long as deceased donor transplants.
Pennye Goodman was also inspired to give 
back after receiving a life-saving kidney in 
2004 from her brother, Gregory Tettemer. 
“Through the generosity of my brother, the skills 
of the Jefferson team and the grace of God, I 
have been blessed with many years of excellent 
health. We are proud to support this new 
Center that will ease the burden of the 
transplant journey for patients and their families.”
Living donor transplants generally work  
better and last almost twice as long as 
deceased donor transplants. With more than 
600 patients on Jefferson’s organ transplant 
wait list, this campaign and the resources 
provided to patients and families in the 
Nicoletti Kidney Transplant Center come at  
a critical time. The Center not only simplifies 
the patient journey, but it also expands  
our dedicated multidiscip linary team and  
supports clinical research. 
To learn about supporting the Nicoletti  
Kidney Transplant Center at Jefferson, visit 
Jefferson.edu/GiveJTI or contact Kelly Austin 
in the Office of Institutional Advancement  
at 215-955-6383.
HOME OF SIDNEY KIMMEL MEDICAL COLLEGE
For more news about the Department follow us on social media.   JeffersonSurgery    @JeffSurgery
Alec Beekley, MD, FACS (Division of Acute Care Surgery), and  
John Entwistle, MD, FACS (Division of Cardiothoracic Surgery), 
have each been promoted to Professor of Surgery.
Howard Todd Massey, MD, has joined  
the Division of Cardiothoracic Surgery as 
the Surgical Director of Cardiac Transplant. 
Dr. Massey completed his general surgery 
residency at the University of Louisville 
and his thoracic and cardiovascular 
surgical residency at the University of 
Texas Southwestern. He then completed 
a fellowship in Heart and Lung Transplantation and Adult Cardiac 
Surgery at the Duke University Medical Center. Dr. Massey is dual-
certified in Surgery and Thoracic Surgery. Under the leadership of 
Dr. Massey and Andrew Boyle, MD, Medical Director of Advanced 
Heart Failure, Jefferson has reactivated its Heart Transplant  
Program with the United Network for Organ Sharing (UNOS).
On March 1, the Jefferson Center for Injury Research and 
Prevention (JCIRP) proudly hosted the 2017 Vision Zero for 
Philadelphia Conference presented by the Bicycle Coalition  
of Greater Philadelphia and Uber. Stanton B. Miller, MD, MPH, 
Founding Director of JCIRP, welcomed an audience including 
urban designers, transportation planners, and representatives  
from AAA, AARP and several city and state agencies. Participants  
will collaborate and implement research-based initiatives to 
eliminate traffic fatalities and serious injuries by 2030, through 
education, engineering and enforcement. JCIRP was established 
in 2013 within the Division of Acute Care Surgery, led by Murray J. 
Cohen, MD, FACS, Director of the Level I Regional Resource Trauma  
Center at Jefferson.
Charles J. Yeo, MD, FACS, Samuel D. Gross Professor and Chair 
of Surgery, has been named Senior Vice President and Chair – 
Enterprise Surgery for Jefferson Health, and Editor-in-Chief of  
the new Journal of Pancreatic Cancer.
On April 29, Theresa Pluth Yeo, PhD,  
MPH, ACNP, Adjunct Associate Professor  
in the Jefferson College of Nursing and  
Co-Director of the Jefferson Pancreas 
Tumor Registry received the 2017 
Distinguished Alumni Award from Cornell 
University – New York Hospital School  
of Nursing.
Save the Date: Jefferson will host the 12th Annual Pancreatic 
Cancer and Related Diseases Symposium on Saturday,  
November 11, 2017 from 9 am to 2 pm. The event gives patients  
and their loved ones an opportunity to connect with expert 
physicians, scientists and staff and learn about the latest 
developments in research and treatment. Seating is limited for  
this free event. Registration is required. Please contact, Kelly Austin  
at 215-955-6383 to request an invitation. For more information, 
visit Jefferson.edu/PancreasEvent.
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